GERRA, LUIGI
GERRA, LUIGI
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients
2024 Boriani, G.; Bonini, N.; Vitolo, M.; Mei, D. A.; Imberti, J. F.; Gerra, L.; Romiti, G. F.; Corica, B.; Proietti, M.; Diemberger, I.; Dan, G. -A.; Potpara, T.; Lip, G. Y.
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting
2023 Boriani, G.; Gerra, L.; Mantovani, M.; Tartaglia, E.; Mei, D. A.; Imberti, J. F.; Vitolo, M.; Bonini, N.
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications
2023 Malavasi, V. L.; Muto, F.; Ceresoli, P. A. C. M.; Menozzi, M.; Righelli, I.; Gerra, L.; Vitolo, M.; Imberti, J. F.; Mei, D. A.; Bonini, N.; Gargiulo, M.; Boriani, G.
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review
2024 Gerra, L.; Bonini, N.; Mei, D. A.; Imberti, J. F.; Vitolo, M.; Bucci, T.; Boriani, G.; Lip, G. Y. H.
Clinical decisions for appropriate management of patients with atrial fibrillation
2024 Boriani, G.; Bonini, N.; Imberti, J. F.; Vitolo, M.; Gerra, L.; Mantovani, M.; Serafini, K.; Birtolo, C.; Tartaglia, E.; Mei, D. A.
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
2024 Boriani, G.; Gerra, L.; Mei, D. A.; Bonini, N.; Vitolo, M.; Proietti, M.; Imberti, J. F.
Implications for clinical decision-making of the NOAH-AFNET 6 and ARTESiA studies: What risk-benefit ratio of anticoagulation in patients with subclinical atrial fibrillation?
2024 Boriani, G.; Mantovani, M.; Birtolo, C.; Righelli, I.; Gerra, L.
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices
2023 Imberti, J. F.; Mei, D. A.; Fontanesi, R.; Gerra, L.; Bonini, N.; Vitolo, M.; Turco, V.; Casali, E.; Boriani, G.
Oral anticoagulants in patients with atrial fibrillation and end-stage renal disease: Walking the tightrope between thromboembolic and bleeding risk
2024 Vitolo, M.; Gerra, L.; Boriani, G.
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction
2023 Barbieri, A.; Imberti, J. F.; Bartolomei, M.; Bonini, N.; Laus, V.; Torlai Triglia, L.; Chiusolo, S.; Stuani, M.; Mari, C.; Muto, F.; Righelli, I.; Gerra, L.; Malaguti, M.; Mei, D. A.; Vitolo, M.; Boriani, G.
Single-lead VDD pacing: a literature review on short-term and long-term performance
2023 Mei, Davide Antonio; Imberti, Jacopo Francesco; Vitolo, Marco; Bonini, Niccolò; Gerra, Luigi; Romiti, Giulio Francesco; Proietti, Marco; Lip, Gregory Y H; Boriani, Giuseppe
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients | 1-gen-2024 | Boriani, G.; Bonini, N.; Vitolo, M.; Mei, D. A.; Imberti, J. F.; Gerra, L.; Romiti, G. F.; Corica, B.; Proietti, M.; Diemberger, I.; Dan, G. -A.; Potpara, T.; Lip, G. Y. | |
| Atrial cardiomyopathy: An entity of emerging interest in the clinical setting | 1-gen-2023 | Boriani, G.; Gerra, L.; Mantovani, M.; Tartaglia, E.; Mei, D. A.; Imberti, J. F.; Vitolo, M.; Bonini, N. | |
| Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications | 1-gen-2023 | Malavasi, V. L.; Muto, F.; Ceresoli, P. A. C. M.; Menozzi, M.; Righelli, I.; Gerra, L.; Vitolo, M.; Imberti, J. F.; Mei, D. A.; Bonini, N.; Gargiulo, M.; Boriani, G. | |
| Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review | 1-gen-2024 | Gerra, L.; Bonini, N.; Mei, D. A.; Imberti, J. F.; Vitolo, M.; Bucci, T.; Boriani, G.; Lip, G. Y. H. | |
| Clinical decisions for appropriate management of patients with atrial fibrillation | 1-gen-2024 | Boriani, G.; Bonini, N.; Imberti, J. F.; Vitolo, M.; Gerra, L.; Mantovani, M.; Serafini, K.; Birtolo, C.; Tartaglia, E.; Mei, D. A. | |
| Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? | 1-gen-2024 | Boriani, G.; Gerra, L.; Mei, D. A.; Bonini, N.; Vitolo, M.; Proietti, M.; Imberti, J. F. | |
| Implications for clinical decision-making of the NOAH-AFNET 6 and ARTESiA studies: What risk-benefit ratio of anticoagulation in patients with subclinical atrial fibrillation? | 1-gen-2024 | Boriani, G.; Mantovani, M.; Birtolo, C.; Righelli, I.; Gerra, L. | |
| Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices | 1-gen-2023 | Imberti, J. F.; Mei, D. A.; Fontanesi, R.; Gerra, L.; Bonini, N.; Vitolo, M.; Turco, V.; Casali, E.; Boriani, G. | |
| Oral anticoagulants in patients with atrial fibrillation and end-stage renal disease: Walking the tightrope between thromboembolic and bleeding risk | 1-gen-2024 | Vitolo, M.; Gerra, L.; Boriani, G. | |
| Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction | 1-gen-2023 | Barbieri, A.; Imberti, J. F.; Bartolomei, M.; Bonini, N.; Laus, V.; Torlai Triglia, L.; Chiusolo, S.; Stuani, M.; Mari, C.; Muto, F.; Righelli, I.; Gerra, L.; Malaguti, M.; Mei, D. A.; Vitolo, M.; Boriani, G. | |
| Single-lead VDD pacing: a literature review on short-term and long-term performance | 1-gen-2023 | Mei, Davide Antonio; Imberti, Jacopo Francesco; Vitolo, Marco; Bonini, Niccolò; Gerra, Luigi; Romiti, Giulio Francesco; Proietti, Marco; Lip, Gregory Y H; Boriani, Giuseppe |